Peter Maag

Insider Reports History

Identity 1 identity field
Location
Brisbane, CA
SEC source record 1 source field
Owner filing signature
/s/ Peter Maag
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Peter Maag

Form 4 holding Director

CareDx, Inc.

Security class
Stock Option (right to buy)
Shares / value
1,250
Estimated value
$6,588
Report date
26 Nov 2024
Price
$5.27
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
349,321
Estimated value
Report date
07 Feb 2024
Price
Ownership
By The Maag Family Irrevocable Trust
Form 4 holding Chief Executive Officer, Director

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
58,220
Estimated value
Report date
07 Feb 2024
Price
Ownership
Direct
Form 4 holding Director

CareDx, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
2,428
Estimated value
Report date
20 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Peter Maag

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .